---
title: "Nano-X Imaging Ltd. (NNOX.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/NNOX.US.md"
symbol: "NNOX.US"
name: "Nano-X Imaging Ltd."
industry: "Health Care Services"
datetime: "2026-05-21T17:42:56.062Z"
locales:
  - [en](https://longbridge.com/en/quote/NNOX.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/NNOX.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/NNOX.US.md)
---

# Nano-X Imaging Ltd. (NNOX.US)

## Company Overview

Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. It provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. The company’s solutions include Nanox Multi Source System comprising Nanox.ARC, a medical tomographic imaging system incorporating its digital X-ray source; and Nanox.

| Item | Detail |
|------|--------|
| Industry | Health Care Services |
| Exchange | US Market |
| Website | [www.nanox.vision](https://www.nanox.vision) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: C
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-21T04:30:18.000Z

**Overall: C (0.56)**

**Industry**: Health Care Services

| Metric | Value |
|--------|-------|
| Industry Ranking | 51 / 87 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: C

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 15.40% |  |
| Net Profit YoY | -40.18% |  |
| P/B Ratio | 0.90 |  |
| Dividend Ratio | 0.00% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 125958312.68 |  |
| Revenue | 13021000.00 |  |

#### Multi Score Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | -45.62% | E |
| Profit Margin | -576.13% | E |
| Gross Margin | -98.21% | E |
| Revenue YoY | 15.40% | B |
| Net Profit YoY | -40.18% | D |
| Total Assets YoY | -22.78% | E |
| Net Assets YoY | -26.11% | E |
| Cash Flow Margin | 54.38% | C |
| OCF YoY | 15.40% | B |
| Turnover | 0.07 | E |
| Gearing Ratio | 13.83% | A |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Nano-X Imaging Ltd.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "15.40%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "-40.18%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "0.90",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.00%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "125958312.68",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "13021000.00",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "C",
      "indicators": [
        {
          "name": "ROE",
          "value": "-45.62%",
          "rating": "E"
        },
        {
          "name": "Profit Margin",
          "value": "-576.13%",
          "rating": "E"
        },
        {
          "name": "Gross Margin",
          "value": "-98.21%",
          "rating": "E"
        },
        {
          "name": "Revenue YoY",
          "value": "15.40%",
          "rating": "B"
        },
        {
          "name": "Net Profit YoY",
          "value": "-40.18%",
          "rating": "D"
        },
        {
          "name": "Total Assets YoY",
          "value": "-22.78%",
          "rating": "E"
        },
        {
          "name": "Net Assets YoY",
          "value": "-26.11%",
          "rating": "E"
        },
        {
          "name": "Cash Flow Margin",
          "value": "54.38%",
          "rating": "C"
        },
        {
          "name": "OCF YoY",
          "value": "15.40%",
          "rating": "B"
        },
        {
          "name": "Turnover",
          "value": "0.07",
          "rating": "E"
        },
        {
          "name": "Gearing Ratio",
          "value": "13.83%",
          "rating": "A"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -1.68 | 40/87 | - | - | - |
| PB | 0.90 | 9/87 | 1.78 | 1.44 | 1.07 |
| PS (TTM) | 9.67 | 63/87 | 26.26 | 19.53 | 13.67 |
| Dividend Yield | 0.00% | - | - | - | - |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Cigna (CI.US) | B | C | A | D | B | B |
| 02 | BrightSpring Health Services - Unit (BTSGU.US) | C | A | A | D | B | B |
| 03 | Fresenius (FSNUY.US) | C | B | C | C | B | B |
| 04 | Quest Diagnostics (DGX.US) | B | B | B | C | B | B |
| 05 | Labcorp (LH.US) | B | B | B | C | B | B |

## Institutional View

### Analyst Rating Distribution

> As of 2026-04-22T04:00:00.000Z

Total Analysts: **4**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 4 | 100% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 1.89 |
| Highest Target | 9.60 |
| Lowest Target | 5.00 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/NNOX.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/NNOX.US/norm.md)
- [Related News](https://longbridge.com/en/quote/NNOX.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/NNOX.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**